These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 34105535)
1. A sulfobetaine zwitterionic polymer-drug conjugate for multivalent paclitaxel and gemcitabine co-delivery. Sun H; Yan L; Zhang R; Lovell JF; Wu Y; Cheng C Biomater Sci; 2021 Jul; 9(14):5000-5010. PubMed ID: 34105535 [TBL] [Abstract][Full Text] [Related]
2. Biodegradable zwitterionic sulfobetaine polymer and its conjugate with paclitaxel for sustained drug delivery. Sun H; Chang MYZ; Cheng WI; Wang Q; Commisso A; Capeling M; Wu Y; Cheng C Acta Biomater; 2017 Dec; 64():290-300. PubMed ID: 29030301 [TBL] [Abstract][Full Text] [Related]
3. A multifunctional biodegradable brush polymer-drug conjugate for paclitaxel/gemcitabine co-delivery and tumor imaging. Sun H; Yan L; Chang MYZ; Carter KA; Zhang R; Slyker L; Lovell JF; Wu Y; Cheng C Nanoscale Adv; 2019; 1(7):2761-2771. PubMed ID: 32864564 [TBL] [Abstract][Full Text] [Related]
4. Zwitterionic Cross-Linked Biodegradable Nanocapsules for Cancer Imaging. Sun H; Yan L; Carter KA; Zhang J; Caserto JS; Lovell JF; Wu Y; Cheng C Langmuir; 2019 Feb; 35(5):1440-1449. PubMed ID: 30086625 [TBL] [Abstract][Full Text] [Related]
5. Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. Meng H; Wang M; Liu H; Liu X; Situ A; Wu B; Ji Z; Chang CH; Nel AE ACS Nano; 2015; 9(4):3540-57. PubMed ID: 25776964 [TBL] [Abstract][Full Text] [Related]
6. Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment. Larson N; Yang J; Ray A; Cheney DL; Ghandehari H; Kopeček J Int J Pharm; 2013 Sep; 454(1):435-43. PubMed ID: 23827653 [TBL] [Abstract][Full Text] [Related]
7. Thermosensitive and biodegradable hydrogel encapsulating targeted nanoparticles for the sustained co-delivery of gemcitabine and paclitaxel to pancreatic cancer cells. Shabana AM; Kambhampati SP; Hsia RC; Kannan RM; Kokkoli E Int J Pharm; 2021 Jan; 593():120139. PubMed ID: 33278494 [TBL] [Abstract][Full Text] [Related]
8. Mixed Liposome Approach for Ratiometric and Sequential Delivery of Paclitaxel and Gemcitabine. Liu Y; Tamam H; Yeo Y AAPS PharmSciTech; 2018 Feb; 19(2):693-699. PubMed ID: 28971370 [TBL] [Abstract][Full Text] [Related]
9. Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment. Kushwah V; Agrawal AK; Dora CP; Mallinson D; Lamprou DA; Gupta RC; Jain S Pharm Res; 2017 Nov; 34(11):2295-2311. PubMed ID: 28795274 [TBL] [Abstract][Full Text] [Related]
10. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction. Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797 [TBL] [Abstract][Full Text] [Related]
11. Dual Delivery of Gemcitabine and Paclitaxel by Wet-Spun Coaxial Fibers Induces Pancreatic Ductal Adenocarcinoma Cell Death, Reduces Tumor Volume, and Sensitizes Cells to Radiation. Wade SJ; Sahin Z; Piper AK; Talebian S; Aghmesheh M; Foroughi J; Wallace GG; Moulton SE; Vine KL Adv Healthc Mater; 2020 Nov; 9(21):e2001115. PubMed ID: 33000905 [TBL] [Abstract][Full Text] [Related]
12. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System. Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660 [TBL] [Abstract][Full Text] [Related]
13. Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer. Liang Y; Tian B; Zhang J; Li K; Wang L; Han J; Wu Z Int J Nanomedicine; 2017; 12():1699-1715. PubMed ID: 28280336 [TBL] [Abstract][Full Text] [Related]
14. Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma. Borsoi C; Leonard F; Lee Y; Zaid M; Elganainy D; Alexander JF; Kai M; Liu YT; Kang Y; Liu X; Koay EJ; Ferrari M; Godin B; Yokoi K Cancer Lett; 2017 Sep; 403():296-304. PubMed ID: 28687352 [TBL] [Abstract][Full Text] [Related]
15. Co-Delivery of Gemcitabine and Paclitaxel in cRGD-Modified Long Circulating Nanoparticles with Asymmetric Lipid Layers for Breast Cancer Treatment. Zhang J; Zhang P; Zou Q; Li X; Fu J; Luo Y; Liang X; Jin Y Molecules; 2018 Nov; 23(11):. PubMed ID: 30405089 [TBL] [Abstract][Full Text] [Related]
16. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy. Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247 [TBL] [Abstract][Full Text] [Related]
17. In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes. Razzazan A; Atyabi F; Kazemi B; Dinarvand R Mater Sci Eng C Mater Biol Appl; 2016 May; 62():614-25. PubMed ID: 26952465 [TBL] [Abstract][Full Text] [Related]
18. The combination of gemcitabine and nab-paclitaxel as a novel effective treatment strategy for undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model. Higuchi T; Kawaguchi K; Miyake K; Oshiro H; Zhang Z; Razmjooei S; Wangsiricharoen S; Igarashi K; Yamamoto N; Hayashi K; Kimura H; Miwa S; Nelson SD; Dry SM; Li Y; Chawla SP; Eilber FC; Singh SR; Tsuchiya H; Hoffman RM Biomed Pharmacother; 2019 Mar; 111():835-840. PubMed ID: 30616082 [TBL] [Abstract][Full Text] [Related]
19. Stimuli-Sensitive Biodegradable and Amphiphilic Block Copolymer-Gemcitabine Conjugates Self-Assemble into a Nanoscale Vehicle for Cancer Therapy. Duan Z; Zhang Y; Zhu H; Sun L; Cai H; Li B; Gong Q; Gu Z; Luo K ACS Appl Mater Interfaces; 2017 Feb; 9(4):3474-3486. PubMed ID: 28029039 [TBL] [Abstract][Full Text] [Related]
20. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer. Mondal G; Almawash S; Chaudhary AK; Mahato RI Mol Pharm; 2017 Sep; 14(9):3121-3133. PubMed ID: 28719220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]